Terms: = Head and neck cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
5 results:
1. Association Between a History of Breast cancer and Decreased Thyroid cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract] [Full Text] [Related]
2. Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence.
Findlay JM; Dickson E; Fiorani C; Bradley KM; Mukherjee S; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 Dec; 29(12):6717-6727. PubMed ID: 31278574
[TBL] [Abstract] [Full Text] [Related]
3. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.
Liu CJ; Lin SC; Chen YJ; Chang KM; Chang KW
Mol Carcinog; 2006 Oct; 45(10):721-31. PubMed ID: 16676365
[TBL] [Abstract] [Full Text] [Related]
4. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract] [Full Text] [Related]
5. Oncogene amplification in squamous cell carcinoma of the head and neck.
Merritt WD; Weissler MC; Turk BF; Gilmer TM
Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1394-8. PubMed ID: 2248738
[TBL] [Abstract] [Full Text] [Related]
